title: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
abstract: Androgen Receptor (AR) signaling is critically important during the development and progression of prostate cancer (PCa). The AR signaling is also important in the development of castrate resistant prostate cancer (CRPC) where AR is functional even after androgen deprivation therapy (ADT); however, little is known regarding the transcriptional and functional regulation of AR in PCa. Moreover, treatment options for primary PCa for preventing the occurrence of CRPC is limited; therefore, novel strategy for direct inactivation of AR is urgently needed. In this study, we found loss of miR-34a, which targets AR, in PCa tissue specimens, especially in patients with higher Gleason grade tumors, consistent with increased expression of AR. Forced overexpression of miR-34a in PCa cell lines led to decreased expression of AR and prostate specific antigen (PSA) as well as the expression of Notch-1, another important target of miR-34a. Most importantly, BR-DIM intervention in PCa patients prior to radical prostatectomy showed re-expression of miR-34a, which was consistent with decreased expression of AR, PSA and Notch-1 in PCa tissue specimens. Moreover, BR-DIM intervention led to nuclear exclusion both in PCa cell lines and in tumor tissues. PCa cells treated with BR-DIM and 5-aza-dC resulted in the demethylation of miR-34a promoter concomitant with inhibition of AR and PSA expression in LNCaP and C4-2B cells. These results suggest, for the first time, epigenetic silencing of miR -34a in PCa, which could be reversed by BR-DIM treatment and, thus BR-DIM could be useful for the inactivation of AR in the treatment of PCa.
authors.affiliation: Departments of Pathology, Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine Detroit, Michigan.
authors.forename: Dejuan
authors.initials: D
authors.lastname: Kong
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Heath
authors.forename: Wei
authors.initials: W
authors.lastname: Chen
authors.forename: Michael
authors.initials: M
authors.lastname: Cher
authors.forename: Isaac
authors.initials: I
authors.lastname: Powell
authors.forename: Lance
authors.initials: L
authors.lastname: Heilbrun
authors.forename: Yiwei
authors.initials: Y
authors.lastname: Li
authors.forename: Shadan
authors.initials: S
authors.lastname: Ali
authors.forename: Seema
authors.initials: S
authors.lastname: Sethi
authors.forename: Oudai
authors.initials: O
authors.lastname: Hassan
authors.forename: Clara
authors.initials: C
authors.lastname: Hwang
authors.forename: Nilesh
authors.initials: N
authors.lastname: Gupta
authors.forename: Dhananjay
authors.initials: D
authors.lastname: Chitale
authors.forename: Wael A
authors.initials: WA
authors.lastname: Sakr
authors.forename: Mani
authors.initials: M
authors.lastname: Menon
authors.forename: Fazlul H
authors.initials: FH
authors.lastname: Sarkar